Application research of artificial intelligence-based lung function assessment technique in radiotherapy of thoracic cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036616

Enrollment

Unknown

Registered

2020-08-24

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thoracic cancer

Interventions

case series:N/A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients with lung cancer, esophageal cancer and mediastinal tumor confirmed histologically or cytologically; 2.Ages 18-75 years; 3.Quality of Life score (KPS score) >= 70; 4.The expected survival time is > more than 6 months; 5.1 second vital capacity (FEV1) predicted > 60%; 6.The patient gives informed consent to the treatment and various examinations.

Exclusion criteria

Exclusion criteria: 1. There are distant organ metastases; 2. Patients had chest radiation therapy, chest surgery, or a history of severe cardiopulmonary disease before; 3. Pregnant and breastfeeding women; 4. Refuse to cooperate with medical treatment and related examinations; 5. Other contraindications to radiotherapy.

Design outcomes

Primary

Measure	Time frame
Functional dosimetric parameters of radiotherapy planning;	—

Secondary

Measure	Time frame
>2 radiation pneumonitis;Progression Free Survival;Radiation dose of tumor tissue;	—

Countries

China

Contacts

Public ContactYong Liu

Department of Radiation Oncology, Shanghai General Hospital

drliuyrt@163.com+86 021-37798364

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026